TCL Archive IOM Panel: NCI Clinical Trials Groups At “Breaking Point,” More Funds Needed. April 16, 2010
TCL Archive Black Women More Likely To Have Aggressive, Less Treatable Breast Cancer September 28, 2007
TCL Archive FDA Approves Abraxane For Second-Line Treatment Of Metastatic Breast Cancer January 28, 2005
TCL Archive DRCCA Board Gives Concept Approval To Nutrition Clinical Trials Which Could Total $52.5 Million January 28, 1983
